Masahiro Kamata
39PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (39)
Sort by Publication Date:
|Mar 08, 2026
A 308-nm Excimer Lamp Ameliorates MC903-Induced Atopic Dermatitis With Reductions of Intraepidermal Nerve Fiber Density and Expression of Thymic Stromal Lymphopoietin.Thalita Bastos, Makoto Ito, Masahiro Kamata
|Oct 25, 2025
Combined Maxacalcitol/Betamethasone Butyrate Propionate Ointment Possesses Long-Term Sustained Effects of Inducing Regulatory T Cells and Downregulating the Th17 Response, Even After Discontinuation of Its Application in Imiquimod-Induced Psoriasiform Dermatitis.Teruo Shimizu, Masahiro Kamata, Hideya Uratsuji
|Oct 16, 2025
Clinical Outcomes of Tralokinumab and Lebrikizumab in Japanese Atopic Dermatitis Patients With Persistent Head and Neck Dermatitis After Long-Term Treatment With Dupilumab: A Single-Center Retrospective Study.Ayu Watanabe, Masahiro Kamata, Yoshiki Okada
|Apr 14, 2025
Incidences of Herpes Zoster and Acne by Age in Japanese Patients With Atopic Dermatitis During Treatment With Baricitinib or Upadacitinib: A Single-Centre Retrospective Study.Ayu Watanabe, Masahiro Kamata, Yoshiki Okada
|Nov 02, 2024
Real-World Experience of 3-Year Treatment With Dupilumab: Significant Decrease in Circulating Neutrophils and Eosinophils in Japanese Patients With Atopic Dermatitis.Hideyuki Nakajima, Masahiro Kamata, Yoshiki Okada
|Oct 21, 2024
Serum interleukin-10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid.Shoya Suzuki, Masahiro Kamata, Hideaki Uchida
Pageof 7
